Clinical Trial Update: Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results for teriflunomide in relapsing forms of multiple sclerosis, reporting relapse reduction and disability outcomes with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-11-06